BerGenBio ASA: BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet.
BerGenBio ASA: New Data on BerGenBio s Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
- Distinguished global experts appointed to strengthen bemcentinib development in STK11m NSCLC - BERGEN, Norway, Feb. 2, 2023 /PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage
/PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet.